STOCK TITAN

Helius Medical Technologies Inc - HSDT STOCK NEWS

Welcome to our dedicated news page for Helius Medical Technologies (Ticker: HSDT), a resource for investors and traders seeking the latest updates and insights on Helius Medical Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Helius Medical Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Helius Medical Technologies's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.21%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.28%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.51%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.41%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.83%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.06%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
conferences
Helius Medical Technologies Inc

Nasdaq:HSDT

HSDT Rankings

HSDT Stock Data

5.47M
829.47k
0.85%
11.59%
8.14%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Newtown

About HSDT

helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.